We are live on ! Find out more
SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

2 hedge funds and large institutions have $4.2M invested in Seelos Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more capital invested

Capital invested by funds: $2.56M → $4.2M (+$1.64M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

33% less funds holding

Funds holding: 3 → 2 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$553K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$263K
2
ARTA
A.R.T. Advisors
New York
-$19K
3
RJFSA
Raymond James Financial Services Advisors
Florida
-$14K
4
Creative Planning
Creative Planning
Kansas
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Sarissa Capital Management
Connecticut
$3.06M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$720K +$553K +2 +200%
Franklin Resources
3
Franklin Resources
California
$107K – – –
Citadel Advisors
4
Citadel Advisors
Florida
$67K – – –
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$54K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$54K – – –
BIP
7
Brandes Investment Partners
California
$38K – – –
Northern Trust
8
Northern Trust
Illinois
$27K – – –
VKH
9
Virtu KCG Holdings
New York
$22K – – –
BlackRock
10
BlackRock
New York
$19K – – –
Morgan Stanley
11
Morgan Stanley
New York
$9K – – –
AIM
12
Acrospire Investment Management
Illinois
$6K – – –
EWM
13
Evercore Wealth Management
New York
$6K – – –
Wells Fargo
14
Wells Fargo
California
$6K – – –
IP
15
Intellectus Partners
California
$3K – – –
FANJ
16
Financial Architects (New Jersey)
New Jersey
$2K – – –
FDCDDQ
17
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.48K – – –
AG
18
Advisor Group
Arizona
$1K – – –
Deutsche Bank
19
Deutsche Bank
Germany
$1K – – –
Group One Trading
20
Group One Trading
Illinois
$1K – – –
Manulife (Manufacturers Life Insurance)
21
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
UBS Group
22
UBS Group
Switzerland
$1K – – –
AFM
23
Anson Funds Management
Texas
– -$263K -2 Closed
ARTA
24
A.R.T. Advisors
New York
– -$19K – –
Creative Planning
25
Creative Planning
Kansas
– -$1K – –
1
2

SEEL Hedge Fund Activity: Q1 2017 in Review

2 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q1 2017, worth a combined $4.2M — up 64% from $2.56M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SEEL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was Vanguard Group, adding an estimated $553K. The largest seller was Anson Funds Management, exiting entirely with an estimated $263K sold.

  • 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q1 2017, down from 3 in Q4 2016.
  • Funds reported $4.2M of Seelos Therapeutics, Inc. Common Stock stock for Q1 2017, up 64% quarter-over-quarter.
  • 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q1 2017 and 1 closed out, a net change of -1 holder.
  • The largest Seelos Therapeutics, Inc. Common Stock buyer in Q1 2017 was Vanguard Group, an estimated $553K added.
  • The largest Seelos Therapeutics, Inc. Common Stock seller in Q1 2017 was Anson Funds Management, an estimated $263K sold.

Based on aggregated 13F filings for Q1 2017.